NCCTG N0821 (Alliance): A phase II first-line study of pemetrexed, carboplatin and bevacizumab in elderly patients with advanced nonsquamous non-small cell lung cancer with good performance status

PURPOSE: We hypothesized that the combination of bevacizumab, carboplatin and pemetrexed will be an effective first-line regimen in fit, elderly patients with nonsquamous NSCLC. PATIENTS AND METHODS: Treatment-naïve, stage IIIB/IV nonsquamous NSCLC patients ≥ 70 years old with good performance statu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dy, Grace K., Molina, Julian R., Qi, Yingwei, Ansari, Rafat, Thomas, Sachdev, Ross, Helen J., Soori, Gamini, Anderson, Daniel, Aubry, Marie Christine, Meyers, Jeffrey, Adjei, Araba A., Mandrekar, Sumithra, Adjei, Alex A.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145612/
https://ncbi.nlm.nih.gov/pubmed/25157767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000217
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares